Home
Clinical Resources Search
PQI: Management of Hyperphosphatemia with a Low-Phosphorous Diet

Management of Hyperphosphatemia with a Low-Phosphorous Diet

Download PQI pdf 0.3MB

Last Updated: December 19, 2023

By: Rachel Moniz, PharmD | Kirollos S. Hanna, PharmD, BCPS, BCOP

About this PQI

This PQI will focus on the management of high serum phosphorous levels (hyperphosphatemia) through dietary interventions.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Brentuximab Vedotin FGFR Inhibitor Gazyva Obinutuzumab Padcev Supportive Care

PQI

Frequently Searched

Supported by

Management of Hyperphosphatemia with a Low-Phosphorous Diet

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Epcoritamab (epcoritamab-bysp) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)

PQI: Ibrutinib Dosing Optimization

PQI: Zanubrutinib (Brukinsa®) Patient Selection and Management

PQI: Zanubrutinib (Brukinsa ®) treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management

PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations

PQI in Action: Siltuximab (Sylvant®) in Patients with Idiopathic Multicentric Castleman Disease

PQI in Action: Isatuximab-irfc (Sarclisa®) in 1q21 Gain or Amplifications in Relapsed/Refractory Multiple Myeloma

The PQI Podcast S8 Ep 12:

The PQI Podcast S8 Ep 11: Honoring Her Legacy: A Conversation with Miss America 2024

The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting

The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program

Readiness Tracker

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Treatment Support Kit: Tivozanib

Treatment Support Kit: Regorafenib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

PQI: Brentuximab Vedotin (Adcetris®) Neuropathy and Neutropenia Management

PQI: FGFR Inhibitor Side Effect Management

PQI: Obinutuzumab (Gazyva®) for Chronic Lymphocytic Leukemia and Follicular Lymphoma

PQI: Ibrutinib (Imbruvica®) Expansion with Obinutuzumab (Gazyva®)

PQI: Obinutuzumab (Gazyva®) for Chronic Lymphocytic Leukemia and Follicular Lymphoma

PQI: Ibrutinib (Imbruvica®) Expansion with Obinutuzumab (Gazyva®)

PQI: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

PQI: Enfortumab Vedotin-ejfv (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma

PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma – 2

PQI in Action: Enfortumab Vedotin (Padcev®) Management for Advanced or Metastatic Urothelial Carcinoma

The PQI Podcast S4 Ep 5: Role of Oncology Social Worker

The PQI Podcast S4 Ep 6 : Community Pharmacy and Ohio Board of Pharmacy

The PQI Podcast S4 Ep 9: Mental Illness and Burnout

The PQI Podcast S4 Ep 10: Oncology Wellness & Exercise

The PQI Podcast S8 Ep 12:

The PQI Podcast S8 Ep 11: Honoring Her Legacy: A Conversation with Miss America 2024

PQI: Epcoritamab (epcoritamab-bysp) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)

PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management